Cellular Neuroscience, Neurodegeneration and Repair (CNNR)

Neurodegenerative diseases, such as Alzheimer’s, Huntington’s and Parkinson’s, and injuries to the brain and spinal cord from trauma orstroke are among the most feared of the disorders that afflict humankind.

The economic impact of these diseases is massive, and their toll in human suffering is incalculable. According to the National Institute on Aging, the direct and indirect costs of caring for patients with Alzheimer’s disease alone are at least $100 billion per year. With a rapidly aging population, the challenges that neurodegenerative diseases pose for our society will only increase.

Decades of research in molecular and cellular biology and neurobiology have revealed a myriad of potential drug targets to slow or prevent these disorders. In an effort to aggressively translate these findings into effective therapies, the School of Medicine has formed a new interdepartmental program in Cellular Neuroscience, Neurodegeneration and Repair (CNNR) that will accelerate the pace of Yale’s research on neurodegenerative diseases and nerve injury and repair.

The CNNR Program at Yale University School of Medicine is located at 295 Congress Ave in the Boyer Center for Molecular Medicine. For more information regarding the program visit their website.